Wayne Godfrey
Equibles does not estimate personal net worth.
About Wayne Godfrey
Janux Therapeutics, Inc. reported in an 8-K filed June 23, 2023 that Wayne Godfrey resigned as Chief Medical Officer, effective July 5, 2023. The proxy statement of Janux Therapeutics, Inc. reports total compensation of $2,287,138 for Wayne Godfrey in fiscal 2022, including a base salary of $435,000. Disclosed compensation is on record for 3 fiscal years.
“On June 21, 2023, Wayne Godfrey, M.D. resigned from his position as Chief Medical Officer of Janux Therapeutics, Inc. (the "Company"), effective July 5, 2023.”
Affiliation history
-
Janux Therapeutics, Inc. (JANX)
Proxy statement
Start not stated–2023-07-05
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Janux Therapeutics, Inc. (JANX) | Chief Medical Officer | $435,000 | $2,287,138 |
| 2021 | Janux Therapeutics, Inc. (JANX) | Chief Medical Officer | $257,045 | $4,277,949 |
| 2020 | Janux Therapeutics, Inc. (JANX) | Chief Medical Officer | — | — |